• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

对《多西他赛与顺铂周疗同步放化疗治疗局部晚期鼻咽癌的倾向评分匹配分析》的勘误

Correction to: Concurrent chemoradiotherapy with weekly docetaxel versus cisplatin in the treatment of locoregionally advanced nasopharyngeal carcinoma: a propensity score matched analysis.

作者信息

Liao Jun-Fang, Zhang Qun, Du Xiao-Jing, Lan Mei, Liu Shan, Xia Yun-Fei, Cai Xiu-Yu, Luo Wei

机构信息

Department of Radiation Oncology, National Cancer Center/National Clinical Research Center For Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, 518116, China.

Department of Radiation Oncology, The First Affiliated Hospital of Sun Yat‑sen University, Guangzhou, 510080, Guangdong, P. R. China.

出版信息

Cancer Commun (Lond). 2019 Sep 23;39(1):50. doi: 10.1186/s40880-019-0396-2.

DOI:10.1186/s40880-019-0396-2
PMID:31547862
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6755687/
Abstract

In the original publication of this article [1], the first affiliation name in the Author details section should be updated to 'Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen 518116, China' because the affiliation has been renamed from Jun. 15th, 2019.

摘要

在本文的原始发表版本[1]中，作者详情部分的第一个单位名称应更新为“中国医学科学院北京协和医学院肿瘤医院（国家癌症中心、国家肿瘤临床医学研究中心）深圳医院放疗科，中国深圳518116”，因为该单位自2019年6月15日起已更名。

相似文献

1
Correction to: Concurrent chemoradiotherapy with weekly docetaxel versus cisplatin in the treatment of locoregionally advanced nasopharyngeal carcinoma: a propensity score matched analysis.对《多西他赛与顺铂周疗同步放化疗治疗局部晚期鼻咽癌的倾向评分匹配分析》的勘误
Cancer Commun (Lond). 2019 Sep 23;39(1):50. doi: 10.1186/s40880-019-0396-2.
2
Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial.诱导化疗加同期放化疗对比单纯同期放化疗治疗局部晚期鼻咽癌：一项 3 期、多中心、随机对照临床试验。
Lancet Oncol. 2016 Nov;17(11):1509-1520. doi: 10.1016/S1470-2045(16)30410-7. Epub 2016 Sep 27.
3
Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial.同期放化疗加辅助化疗与单纯同期放化疗治疗局部晚期鼻咽癌患者的随机对照 3 期多中心临床试验。
Lancet Oncol. 2012 Feb;13(2):163-71. doi: 10.1016/S1470-2045(11)70320-5. Epub 2011 Dec 7.
4
Induction chemotherapy plus IMRT alone versus induction chemotherapy plus IMRT-based concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study.局部晚期鼻咽癌诱导化疗加 IMRT 与诱导化疗加基于 IMRT 的同期放化疗的回顾性队列研究。
J Cancer Res Clin Oncol. 2019 Jul;145(7):1857-1864. doi: 10.1007/s00432-019-02925-z. Epub 2019 May 6.
5
Chemoradiotherapy with weekly low-dose docetaxel and cisplatin concurrent with radiation for patients with locally advanced nasopharyngeal carcinoma, followed by adjuvant chemotherapy for selected patients.对于局部晚期鼻咽癌患者，采用每周低剂量多西他赛和顺铂同步放化疗，并联合放疗，随后对部分患者进行辅助化疗。
Jpn J Clin Oncol. 2016 Oct;46(10):903-910. doi: 10.1093/jjco/hyw100. Epub 2016 Jul 29.
6
Addition of 5-fluorouracil to first-line induction chemotherapy with docetaxel and cisplatin before concurrent chemoradiotherapy does not improve survival in locoregionally advanced nasopharyngeal carcinoma.在同步放化疗前，将5-氟尿嘧啶添加到多西他赛和顺铂的一线诱导化疗中，并不会提高局部晚期鼻咽癌患者的生存率。
Oncotarget. 2017 Aug 7;8(53):91150-91161. doi: 10.18632/oncotarget.20017. eCollection 2017 Oct 31.
7
Effect of induction chemotherapy with cisplatin, fluorouracil, with or without taxane on locoregionally advanced nasopharyngeal carcinoma: a retrospective, propensity score-matched analysis.顺铂、氟尿嘧啶诱导化疗联合或不联合紫杉类药物治疗局部晚期鼻咽癌的疗效：回顾性、倾向评分匹配分析。
Cancer Commun (Lond). 2018 May 10;38(1):21. doi: 10.1186/s40880-018-0283-2.
8
Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study.基于基因表达signature 预测局部晚期鼻咽癌远处转移的建立和验证：一项回顾性、多中心队列研究。
Lancet Oncol. 2018 Mar;19(3):382-393. doi: 10.1016/S1470-2045(18)30080-9. Epub 2018 Feb 7.
9
Concurrent cisplatin and 5-fluorouracil versus concurrent cisplatin and docetaxel with radiotherapy for esophageal squamous cell carcinoma: a propensity score-matched analysis.顺铂与5-氟尿嘧啶同步放化疗对比顺铂与多西他赛同步放化疗治疗食管鳞状细胞癌：一项倾向评分匹配分析
Oncotarget. 2016 Jul 12;7(28):44686-44694. doi: 10.18632/oncotarget.9301.
10
Predictive value of excision repair cross- complementation group 1 expression in locoregionally advanced nasopharyngeal carcinoma receiving cisplatin-based concurrent chemoradiotherapy.切除修复交叉互补基因 1 表达对接受顺铂同期放化疗的局部晚期鼻咽癌的预测价值。
Cancer Biomark. 2018;21(4):875-881. doi: 10.3233/CBM-170817.

本文引用的文献

1
Concurrent chemoradiotherapy with weekly docetaxel versus cisplatin in the treatment of locoregionally advanced nasopharyngeal carcinoma: a propensity score-matched analysis.同期放化疗联合每周多西紫杉醇与顺铂治疗局部晚期鼻咽癌：倾向评分匹配分析。
Cancer Commun (Lond). 2019 Jun 27;39(1):40. doi: 10.1186/s40880-019-0380-x.